Industry wins reprieve as European ministers postpone ban on animal-derived risk materials
This article was originally published in Clinica
The European Council of Ministers has voted to postpone the European Commission's ban on materials containing specified risk materials for another year. This means that the medical devices industry will not have to respond after January 1, as had been expected. The Council took its decision just two weeks before the ban (Decision 97/534) was due to take effect.
You may also be interested in...
Health policy changes that President-elect Joe Biden will likely make during his four-year term include Medicaid expansion and a greater reliance on medical science, among others, experts say.
Already cleared to monitor the viral load in HIV-positive individuals, the test has now been approved for initial diagnosis as well.
As with its first two approved RNAi therapies, Alnylam will negotiate value-based agreements with payers, but for Oxlumo, approved in pediatric patients, it will offer a patient need adjustment.